NextGen Healthcare, Inc. (NASDAQ:NXGN) Shares Sold by Lazard Asset Management LLC

Lazard Asset Management LLC trimmed its holdings in NextGen Healthcare, Inc. (NASDAQ:NXGNGet Rating) by 58.3% during the second quarter, Holdings Channel reports. The institutional investor owned 10,316 shares of the company’s stock after selling 14,407 shares during the period. Lazard Asset Management LLC’s holdings in NextGen Healthcare were worth $179,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Clifford Capital Partners LLC acquired a new stake in NextGen Healthcare in the 2nd quarter worth about $579,000. MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income raised its holdings in shares of NextGen Healthcare by 124.1% in the 2nd quarter. MESIROW FINANCIAL INVESTMENT MANAGEMENT Equity & Fixed Income now owns 503,178 shares of the company’s stock worth $8,775,000 after purchasing an additional 278,607 shares during the period. Texas Permanent School Fund raised its holdings in shares of NextGen Healthcare by 1.9% in the 2nd quarter. Texas Permanent School Fund now owns 40,596 shares of the company’s stock worth $708,000 after purchasing an additional 776 shares during the period. State Board of Administration of Florida Retirement System raised its holdings in shares of NextGen Healthcare by 58.7% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 144,698 shares of the company’s stock worth $2,524,000 after purchasing an additional 53,514 shares during the period. Finally, MQS Management LLC purchased a new position in shares of NextGen Healthcare in the 2nd quarter worth about $176,000. 73.80% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently commented on NXGN. SVB Leerink raised their price objective on NextGen Healthcare from $24.00 to $25.00 and gave the stock an “outperform” rating in a report on Wednesday, October 26th. Truist Financial began coverage on NextGen Healthcare in a report on Wednesday, September 7th. They issued a “hold” rating and a $20.00 price objective on the stock. TheStreet upgraded NextGen Healthcare from a “c” rating to a “b-” rating in a report on Wednesday, October 26th. StockNews.com upgraded NextGen Healthcare from a “buy” rating to a “strong-buy” rating in a report on Thursday, October 27th. Finally, Piper Sandler reiterated a “neutral” rating and set a $20.00 target price on shares of NextGen Healthcare in a report on Friday, October 21st. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $22.75.

NextGen Healthcare Stock Up 0.6 %

Shares of NASDAQ NXGN opened at $20.17 on Monday. NextGen Healthcare, Inc. has a fifty-two week low of $15.32 and a fifty-two week high of $21.99. The business has a 50 day moving average price of $18.53 and a two-hundred day moving average price of $18.01. The firm has a market cap of $1.36 billion, a PE ratio of 65.06 and a beta of 1.00.

Insider Buying and Selling at NextGen Healthcare

In other NextGen Healthcare news, EVP Mitchell Waters sold 3,889 shares of the firm’s stock in a transaction that occurred on Wednesday, October 26th. The stock was sold at an average price of $20.00, for a total transaction of $77,780.00. Following the completion of the sale, the executive vice president now owns 62,725 shares in the company, valued at approximately $1,254,500. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other NextGen Healthcare news, EVP Mitchell Waters sold 3,889 shares of the firm’s stock in a transaction that occurred on Wednesday, October 26th. The stock was sold at an average price of $20.00, for a total transaction of $77,780.00. Following the completion of the sale, the executive vice president now owns 62,725 shares in the company, valued at approximately $1,254,500. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CTO David A. Metcalfe sold 32,372 shares of NextGen Healthcare stock in a transaction that occurred on Tuesday, November 1st. The stock was sold at an average price of $20.00, for a total value of $647,440.00. Following the completion of the transaction, the chief technology officer now owns 178,984 shares of the company’s stock, valued at approximately $3,579,680. The disclosure for this sale can be found here. Insiders sold a total of 78,416 shares of company stock worth $1,580,010 in the last 90 days. 4.50% of the stock is owned by corporate insiders.

About NextGen Healthcare

(Get Rating)

NextGen Healthcare, Inc provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions.

Featured Stories

Want to see what other hedge funds are holding NXGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NextGen Healthcare, Inc. (NASDAQ:NXGNGet Rating).

Institutional Ownership by Quarter for NextGen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.